Mason Street Advisors LLC cut its position in Cognex Co. (NASDAQ:CGNX) by 2.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 89,499 shares of the scientific and technical instruments company’s stock after selling 1,840 shares during the period. Mason Street Advisors LLC owned 0.05% of Cognex worth $4,397,000 as of its most recent SEC filing.
A number of other large investors have also recently added to or reduced their stakes in the business. NEXT Financial Group Inc lifted its position in shares of Cognex by 1,081.8% during the second quarter. NEXT Financial Group Inc now owns 520 shares of the scientific and technical instruments company’s stock worth $25,000 after purchasing an additional 476 shares in the last quarter. Bartlett & Co. LLC bought a new stake in Cognex in the third quarter valued at approximately $25,000. Huntington National Bank increased its stake in Cognex by 173.6% in the second quarter. Huntington National Bank now owns 632 shares of the scientific and technical instruments company’s stock valued at $30,000 after purchasing an additional 401 shares in the last quarter. Coastal Capital Group Inc. bought a new stake in Cognex in the second quarter valued at approximately $38,000. Finally, Quadrant Capital Group LLC increased its stake in Cognex by 622.3% in the third quarter. Quadrant Capital Group LLC now owns 1,199 shares of the scientific and technical instruments company’s stock valued at $56,000 after purchasing an additional 1,033 shares in the last quarter. Hedge funds and other institutional investors own 91.94% of the company’s stock.
CGNX has been the subject of several recent analyst reports. Robert W. Baird upped their target price on shares of Cognex from $42.00 to $47.00 and gave the company a “neutral” rating in a research note on Monday, September 23rd. Daiwa Capital Markets set a $53.00 price objective on shares of Cognex and gave the stock a “hold” rating in a research report on Tuesday, September 24th. DA Davidson increased their price objective on shares of Cognex from $40.00 to $45.00 and gave the stock a “neutral” rating in a research report on Monday, September 23rd. ValuEngine downgraded shares of Cognex from a “sell” rating to a “strong sell” rating in a research report on Monday, October 14th. Finally, Zacks Investment Research raised shares of Cognex from a “sell” rating to a “hold” rating in a research report on Monday, November 4th. Two research analysts have rated the stock with a sell rating, eight have given a hold rating, two have given a buy rating and one has issued a strong buy rating to the company’s stock. Cognex presently has an average rating of “Hold” and an average target price of $50.45.
Cognex (NASDAQ:CGNX) last announced its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.24 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.21 by $0.03. Cognex had a net margin of 22.55% and a return on equity of 14.21%. The business had revenue of $183.33 million during the quarter, compared to analysts’ expectations of $177.78 million. During the same quarter in the prior year, the company posted $0.45 earnings per share. The firm’s revenue was down 21.1% on a year-over-year basis. On average, equities research analysts anticipate that Cognex Co. will post 0.82 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 29th. Investors of record on Friday, November 15th will be issued a dividend of $0.055 per share. This is a boost from Cognex’s previous quarterly dividend of $0.05. The ex-dividend date is Thursday, November 14th. This represents a $0.22 annualized dividend and a yield of 0.43%. Cognex’s dividend payout ratio is presently 16.13%.
In other Cognex news, insider Laura Ann Macdonald sold 24,000 shares of the stock in a transaction on Thursday, October 31st. The shares were sold at an average price of $51.35, for a total value of $1,232,400.00. Following the completion of the sale, the insider now owns 24,000 shares in the company, valued at $1,232,400. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Sheila Marie Dipalma sold 79,500 shares of the stock in a transaction on Friday, November 1st. The shares were sold at an average price of $51.81, for a total transaction of $4,118,895.00. Following the completion of the sale, the senior vice president now owns 10,000 shares of the company’s stock, valued at approximately $518,100. The disclosure for this sale can be found here. Insiders have sold 296,202 shares of company stock valued at $15,570,219 in the last 90 days. 5.60% of the stock is currently owned by corporate insiders.
Cognex Company Profile
Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. It provides machine vision products, which are used to automate the manufacture and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.